Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-27.90M
↓ 79% vs avg
Percentile
P29
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-15.59M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-27.90M | +16.8% |
| 2024 | $-33.54M | -18.4% |
| 2023 | $-28.32M | -49.4% |
| 2022 | $-18.96M | -77.7% |
| 2021 | $-10.67M | -162.3% |
| 2020 | $-4.07M | -1761.6% |
| 2019 | $-218444.00 | +79.6% |
| 2018 | $-1.07M | - |